Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic and Predictive Markers of Treatment Response in Patients With Pancreatic Adenocarcinoma

NCT05776342 is registered in ClinicalTrials.gov with GERCOR - Multidisciplinary Oncology Cooperative Group as lead sponsor.

NCT NCT05776342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05776342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic and Predictive Markers of Treatment Response in Patients With Pancreatic Adenocarcinoma
Lead sponsor
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2003
Completion date
December 31, 2031
Enrollment
4,050 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic adenocarcinoma